During the last session, Afya Limited (NASDAQ:AFYA)’s traded shares were 0.4 million. At the end of the trading day, the stock’s price was $11.63, reflecting an intraday gain of 3.93% or $0.44. The 52-week high for the AFYA share is $28.23, that puts it down -142.73 from that peak though still a striking 6.28% gain since the share price plummeted to a 52-week low of $10.90. The company’s market capitalization is $1.09B, and the average trade volume was 232.37K shares over the past three months.
Afya Limited (AFYA) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.30. AFYA has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.22.
Afya Limited (NASDAQ:AFYA) trade information
Afya Limited (AFYA) registered a 3.93% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.93% in intraday trading to $11.63 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -12.49%, and it has moved by -13.27% in 30 days. Based on these gigs, the overall price performance for the year is -49.54%.
The consensus price target of analysts on Wall Street is $97.84, which implies an increase of 88.11% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $79.81 and $116.72 respectively. As a result, AFYA is trading at a discount of -903.61% off the target high and -586.24% off the low.
Afya Limited (AFYA) estimates and forecasts
Statistics show that Afya Limited has underperformed its competitors in share price, compared to the industry in which it operates. Afya Limited (AFYA) shares have gone down -25.26% during the last six months, with a year-to-date growth rate less than the industry average at 9.64% against 10.60. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 22.20% this quarter and then jump 18.20% in the quarter after that. In the rating firms’ projections, revenue will increase 27.10% compared to the previous financial year.
Revenue for the current quarter is expected to be $88.42 million as predicted by 4 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $98.8 million by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $68.39 million and $77.94 million respectively. In this case, analysts expect current quarter sales to grow by 29.30% and then jump by 26.80% in the coming quarter.
While earnings are projected to return -23.90% in 2022, the next five years will return 3.56% per annum.
Afya Limited is due to release its next quarterly earnings between April 06 and April 11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Afya Limited (NASDAQ:AFYA)’s Major holders
Afya Limited insiders own 18.86% of total outstanding shares while institutional holders control 65.75%, with the float percentage being 81.03%. BAMCO Inc. is the largest shareholder of the company, while 91 institutions own stock in it. As of Sep 29, 2021, the company held over 4.15 million shares (or 9.19% of all shares), a total value of $81.82 million in shares.
The next largest institutional holding, with 2.7 million shares, is of Ameriprise Financial, Inc.’s that is approximately 5.98% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $53.21 million.
Also, the Mutual Funds coming in first place with the largest holdings of Afya Limited (AFYA) shares are Baron Emerging Markets Fund and Baron Global Advantage Fund. Data provided on Sep 29, 2021 indicates that Baron Emerging Markets Fund owns about 2.17 million shares. This amounts to just over 4.81 percent of the company’s overall shares, with a $42.86 million market value. The same data shows that the other fund manager holds slightly less at 1.35 million, or about 2.99% of the stock, which is worth about $26.66 million.